Scientific Director
Novo Nordisk
Maaleov, Denmark
Philip Jonas Sassene has 10+ years of experience with enabling formulations with particular emphasis on the development of new enabling formulation strategies for oral delivery of peptides & proteins including He is currently employed as a Scientific Director within oral delivery technologies at Novo Nordisk A/S, Denmark.
Disclosure information not submitted.
Development of a Novel Antibody-Based Oral Factor VIII Mimetic Drug Candidate (Inno8)
Tuesday, July 15, 2025
2:29 PM – 2:54 PM EDT